This department is offering the Cutting-Edge Basic Research Award to foster highly innovative research related to substance use disorders. The grant supports high-risk research that tests significant hypotheses or develops revolutionary techniques for addiction research, aiming to transform current thinking in the field. The award seeks proposals with limited precedent or preliminary data that have the potential to have a high impact on the understanding and treatment of substance use disorders. Closing date for submissions is Feb 10, 2021, 12:00:00 AM EST.
Opportunity ID: 299918
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-437 |
Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 09, 2018 |
Last Updated Date: | May 29, 2019 |
Original Closing Date for Applications: | Dec 18, 2020 |
Current Closing Date for Applications: | Feb 10, 2021 |
Archive Date: | Mar 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio. The proposed research should: (1) test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking; and/or (2) develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Updated expiration date in accordance with NOT-DA-19-042 | May 29, 2019 | |
Jan 09, 2018 |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-437 |
Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Jan 09, 2018 |
Last Updated Date: | May 29, 2019 |
Original Closing Date for Applications: | Dec 18, 2020 |
Current Closing Date for Applications: | Feb 10, 2021 |
Archive Date: | Mar 12, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education State governments For profit organizations other than small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio. The proposed research should: (1) test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking; and/or (2) develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-437 |
Funding Opportunity Title: | Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 09, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Dec 18, 2020 |
Archive Date: | Jan 23, 2021 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Public and State controlled institutions of higher education County governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education State governments Small businesses Native American tribal governments (Federally recognized) For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA’s current portfolio. The proposed research should: (1) test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking; and/or (2) develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237464 | Jul 20, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260002 | Jul 20, 2018 | Feb 10, 2021 | View |
Package 1
Mandatory forms
299918 RR_SF424_2_0-2.0.pdf
299918 PHS398_CoverPageSupplement_4_0-4.0.pdf
299918 RR_OtherProjectInfo_1_4-1.4.pdf
299918 PerformanceSite_2_0-2.0.pdf
299918 RR_KeyPersonExpanded_2_0-2.0.pdf
299918 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299918 RR_Budget_1_4-1.4.pdf
299918 RR_SubawardBudget30_1_4-1.4.pdf
299918 PHS398_ModularBudget_1_2-1.2.pdf
299918 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299918 RR_SF424_2_0-2.0.pdf
299918 PHS398_CoverPageSupplement_5_0-5.0.pdf
299918 RR_OtherProjectInfo_1_4-1.4.pdf
299918 PerformanceSite_2_0-2.0.pdf
299918 RR_KeyPersonExpanded_2_0-2.0.pdf
299918 PHS398_ResearchPlan_4_0-4.0.pdf
299918 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299918 RR_Budget_1_4-1.4.pdf
299918 RR_SubawardBudget30_1_4-1.4.pdf
299918 PHS398_ModularBudget_1_2-1.2.pdf
299918 PHS_AssignmentRequestForm_3_0-3.0.pdf